CNB Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $409K | Sell |
6,746
-113
| -2% | -$6.59K | 0.17% | 103 |
|
|
2025
Q4 | $370K | Sell |
6,859
-632
| -8% | -$30.4K | 0.15% | 109 |
|
|
2025
Q3 | $338K | Buy |
7,491
+1,350
| +22% | +$63K | 0.14% | 118 |
|
|
2025
Q2 | $284K | Sell |
6,141
-150
| -2% | -$7.36K | 0.13% | 124 |
|
|
2025
Q1 | $384K | Sell |
6,291
-548
| -8% | -$31.9K | 0.19% | 111 |
|
|
2024
Q4 | $387K | Sell |
6,839
-410
| -6% | -$22.9K | 0.18% | 113 |
|
|
2024
Q3 | $375K | Sell |
7,249
-500
| -6% | -$23.5K | 0.17% | 123 |
|
|
2024
Q2 | $322K | Sell |
7,749
-822
| -10% | -$36.8K | 0.15% | 135 |
|
|
2024
Q1 | $465K | Sell |
8,571
-430
| -5% | -$21.9K | 0.23% | 109 |
|
|
2023
Q4 | $462K | Sell |
9,001
-105
| -1% | -$5.51K | 0.25% | 103 |
|
|
2023
Q3 | $529K | Buy |
9,106
+317
| +4% | +$19.4K | 0.31% | 88 |
|
|
2023
Q2 | $562K | Buy |
8,789
+489
| +6% | +$32.8K | 0.33% | 82 |
|
|
2023
Q1 | $575K | Sell |
8,300
-150
| -2% | -$10.6K | 0.35% | 78 |
|
|
2022
Q4 | $608K | Sell |
8,450
-160
| -2% | -$12.1K | 0.38% | 69 |
|
|
2022
Q3 | $612K | Sell |
8,610
-434
| -5% | -$31.5K | 0.41% | 68 |
|
|
2022
Q2 | $696K | Sell |
9,044
-417
| -4% | -$31.8K | 0.45% | 65 |
|
|
2022
Q1 | $691K | Sell |
9,461
-475
| -5% | -$31.9K | 0.39% | 70 |
|
|
2021
Q4 | $620K | Sell |
9,936
-183
| -2% | -$10.7K | 0.34% | 83 |
|
|
2021
Q3 | $599K | Sell |
10,119
-406
| -4% | -$26.7K | 0.36% | 85 |
|
|
2021
Q2 | $703K | Buy |
10,525
+170
| +2% | +$11.1K | 0.44% | 71 |
|
|
2021
Q1 | $654K | Sell |
10,355
-60
| -0.6% | -$3.73K | 0.45% | 67 |
|
|
2020
Q4 | $646K | Sell |
10,415
-408
| -4% | -$25.1K | 0.49% | 64 |
|
|
2020
Q3 | $653K | Sell |
10,823
-3,031
| -22% | -$182K | 0.55% | 55 |
|
|
2020
Q2 | $815K | Sell |
13,854
-899
| -6% | -$53.8K | 0.72% | 40 |
|
|
2020
Q1 | $822K | Sell |
14,753
-2,043
| -12% | -$125K | 0.89% | 30 |
|
|
2019
Q4 | $1.08M | Buy |
16,796
+1,535
| +10% | +$87.9K | 0.91% | 26 |
|
|
2019
Q3 | $774K | Sell |
15,261
-2,284
| -13% | -$107K | 0.72% | 38 |
|
|
2019
Q2 | $796K | Sell |
17,545
-1,314
| -7% | -$61.2K | 0.68% | 41 |
|
|
2019
Q1 | $900K | Buy |
18,859
+1,517
| +9% | +$75.6K | 0.46% | 34 |
|
|
2018
Q4 | $902K | Buy |
17,342
+732
| +4% | +$39.3K | 0.57% | 27 |
|
|
2018
Q3 | $1.03M | Sell |
16,610
-482
| -3% | -$28.6K | 0.59% | 23 |
|
|
2018
Q2 | $946K | Sell |
17,092
-136
| -0.8% | -$7.34K | 0.55% | 25 |
|
|
2018
Q1 | $1.09M | Buy |
17,228
+1,728
| +11% | +$111K | 0.64% | 23 |
|
|
2017
Q4 | $950K | Buy |
+15,500
| New | +$969K | 0.57% | 28 |
|
Other funds holding BMY
VCM
VPM
CNB Bank's BMY Position: Q1 2026 in Review
CNB Bank reduced its Bristol-Myers Squibb (BMY) stake by 1.6% in Q1 2026, selling an estimated $6.59K and leaving 6,746 shares worth $409K. The position accounts for 0.17% of the portfolio, ranked #103.
CNB Bank first reported a position in BMY in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.09M in Q1 2018. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- CNB Bank held 6,746 shares of Bristol-Myers Squibb worth $409K as of Q1 2026.
- CNB Bank sold 113 Bristol-Myers Squibb shares in Q1 2026, an estimated $6.59K.
- Bristol-Myers Squibb made up 0.17% of CNB Bank's portfolio in Q1 2026, its #103 holding.
- CNB Bank first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 34 quarters since.
- CNB Bank's Bristol-Myers Squibb position peaked at $1.09M in Q1 2018.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on CNB Bank's 13F filing for Q1 2026, filed 6 May 2026.